Company profile
RESMED INC insider acquisitions
Company CIK 0000943819 · Reported insider acquisitions and filing context.
These are company listings. A transaction is linked to a particular security only when the filing provides enough information.
Company activity summary
By transaction date, as of October 23, 2026.
No records are loaded for this 7-day transaction window. This does not establish that no transactions occurred.
Known purchase value sums available amounts for non-derivative purchases only. Missing amounts are excluded. “Currency not specified” does not establish that the amounts share a currency. These summaries use all matching loaded records, while the timeline below covers only the current page.
Transaction timeline
Who reported an acquisition, and when the transaction occurred.
26 dated transactions · 8 of 15 reporting owners shown. Select one owner to focus the chart.
View timeline as a table
| Transaction date | Company / security | Reporting owners | Acquisition type |
|---|---|---|---|
| Oct 7, 2026 | RESMED INCResMed Common Stock | Farrell Michael J. | Exercise / conversion |
| Aug 14, 2026 | RESMED INCResMed Common Stock | Leong Justin | Stock award |
| Aug 14, 2026 | RESMED INCResMed Common Stock | Rider Michael J | Stock award |
| Aug 14, 2026 | RESMED INCResMed Common Stock | Farrell Michael J. | Stock award |
| Aug 14, 2026 | RESMED INCResMed Common Stock | Bloomer Aaron | Stock award |
| Dec 8, 2025 | RESMED INCResMed Common Stock | Farrell Michael J. | Exercise / conversion |
| Nov 24, 2025 | RESMED INCResMed Common Stock Options | Farrell Michael J. | Stock award |
| Nov 24, 2025 | RESMED INCResMed Common Stock Options | FARRELL PETER C | Stock award |
| Nov 24, 2025 | RESMED INCResMed Common Stock Options | Mowad-Nassar Nicole | Stock award |
| Nov 20, 2025 | RESMED INCReMed Common Stock | Leong Justin | Stock award |
| Nov 20, 2025 | RESMED INCResMed Common Stock | Hernandez John | Stock award |
| Nov 20, 2025 | RESMED INCResMed Common Stock | Mowad-Nassar Nicole | Stock award |
| Nov 20, 2025 | RESMED INCResMed Common Stock | Tan Desney | Stock award |
| Nov 20, 2025 | RESMED INCResMed Common Stock | Gill Harjit | Stock award |
| Nov 20, 2025 | RESMED INCResMed Common Stock | Drexler Karen | Stock award |
| Nov 20, 2025 | RESMED INCResMed Common Stock | Burt Carol | Stock award |
| Nov 20, 2025 | RESMED INCResMed Common Stock | TAYLOR RONALD R | Stock award |
| Nov 20, 2025 | RESMED INCResMed Common Stock | Sandercock Brett | Stock award |
| Nov 20, 2025 | RESMED INCResMed Common Stock | Farrell Michael J. | Stock award |
| Nov 20, 2025 | RESMED INCResMed Common Stock | DelOrefice Christopher | Stock award |
| Nov 20, 2025 | RESMED INCReMed Common Stock | De Witte Jan | Stock award |
| Nov 20, 2025 | RESMED INCResMed Common Stock | FARRELL PETER C | Stock award |
| Nov 14, 2025 | RESMED INCResMed Common Stock | FARRELL PETER C | Exercise / conversion |
| Nov 7, 2025 | RESMED INCResMed Common Stock | Farrell Michael J. | Exercise / conversion |
| Nov 7, 2025 | RESMED INCResMed Common Stock | Farrell Michael J. | Exercise / conversion |
| Nov 3, 2025 | RESMED INCResMed Common Stock | Sandercock Brett | Exercise / conversion |
Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.
Share price & reported acquisitions
Daily closing prices from a separate source. The date window above also filters prices; reporting-owner and transaction-type selections filter the markers.
Price history is not available
Market-price history is not connected yet.
RMD · Currency not specified. A marker uses that day's closing price, not the reported transaction price. No price is substituted for a missing trading day.
Reported acquisitions
Filing-date filters apply to the list and timeline. The summary above uses transaction dates.
| Filed / transacted | Reporting owners | Type / security | Quantity | Price / reference value | Details |
|---|---|---|---|---|---|
| Trade: | Farrell Michael J.Chairman and CEO · Director | Exercise / conversionResMed Common StockNon-derivative security · Code M | 4,991 | 146.34Value: 730,382.94Currency not specified | View ↗ |
| Trade: | Leong JustinChief Product Officer | Stock awardResMed Common StockNon-derivative security · Code A | 6,461 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Rider Michael JGlobal General Counsel | Stock awardResMed Common StockNon-derivative security · Code A | 3,230 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Farrell Michael J.Chairman and CEO · Director | Stock awardResMed Common StockNon-derivative security · Code A | 13,547 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Bloomer AaronChief Financial Officer | Stock awardResMed Common StockNon-derivative security · Code A | 9,072 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Farrell Michael J.Chairman and CEO · Director | Exercise / conversionResMed Common StockNon-derivative security · Code M | 4,991 | 146.34Value: 730,382.94Currency not specified | View ↗ |
| Trade: | Farrell Michael J.Chairman and CEO · Director | Stock awardResMed Common Stock OptionsDerivative security · Code A | 33,288 | 250.52Value: 8,339,309.76Currency not specified | View ↗ |
| Trade: | FARRELL PETER CDirector | Stock awardResMed Common Stock OptionsDerivative security · Code A | 1,331 | 250.52Value: 333,442.12Currency not specified | View ↗ |
| Trade: | Mowad-Nassar NicoleDirector | Stock awardResMed Common Stock OptionsDerivative security · Code A | 1,331 | 250.52Value: 333,442.12Currency not specified | View ↗ |
| Trade: | Leong JustinChief Product Officer | Stock awardReMed Common StockNon-derivative security · Code A | 1,848 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Hernandez JohnDirector | Stock awardResMed Common StockNon-derivative security · Code A | 1,073 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Mowad-Nassar NicoleDirector | Stock awardResMed Common StockNon-derivative security · Code A | 536 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Tan DesneyDirector | Stock awardResMed Common StockNon-derivative security · Code A | 1,073 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Gill HarjitDirector | Stock awardResMed Common StockNon-derivative security · Code A | 1,073 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Drexler KarenDirector | Stock awardResMed Common StockNon-derivative security · Code A | 1,073 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Burt CarolDirector | Stock awardResMed Common StockNon-derivative security · Code A | 1,073 | 0Value: 0Currency not specified | View ↗ |
| Trade: | TAYLOR RONALD RDirector | Stock awardResMed Common StockNon-derivative security · Code A | 1,073 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Sandercock BrettChief Financial Officer | Stock awardResMed Common StockNon-derivative security · Code A | 2,710 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Farrell Michael J.Chairman and CEO · Director | Stock awardResMed Common StockNon-derivative security · Code A | 13,551 | 0Value: 0Currency not specified | View ↗ |
| Trade: | DelOrefice ChristopherDirector | Stock awardResMed Common StockNon-derivative security · Code A | 1,073 | 0Value: 0Currency not specified | View ↗ |
| Trade: | De Witte JanDirector | Stock awardReMed Common StockNon-derivative security · Code A | 1,073 | 0Value: 0Currency not specified | View ↗ |
| Trade: | FARRELL PETER CDirector | Stock awardResMed Common StockNon-derivative security · Code A | 536 | 0Value: 0Currency not specified | View ↗ |
| Trade: | FARRELL PETER CDirector | Exercise / conversionResMed Common StockNon-derivative security · Code M | 11,442 | 101.64Value: 1,162,964.88Currency not specified | View ↗ |
| Trade: | Farrell Michael J.Chairman and CEO · Director | Exercise / conversionResMed Common StockNon-derivative security · Code M | 7,028 | 101.64Value: 714,325.92Currency not specified | View ↗ |
| Trade: | Farrell Michael J.Chairman and CEO · Director | Exercise / conversionResMed Common StockNon-derivative security · Code M | 983 | 101.64Value: 99,912.12Currency not specified | View ↗ |
| Trade: | Sandercock BrettChief Financial Officer | Exercise / conversionResMed Common StockNon-derivative security · Code M | 2,000 | 101.64Value: 203,280Currency not specified | View ↗ |
26 transactions on this page. Filing date, newest first.
Reporting owners are associated with a filing. Jointly reported amounts are not allocated to individual owners. Historical coverage is still being built. Read the methodology →